LINDSEY SCHWADERER: Open Payments
NPI 1073027314 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 6 payments from 4 companies in 2025. Trend: 2023 $217 · 2024 $246 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
Products named: FARXIGA, CAMZYOS, LEQVIO, AMVUTTRA.
Industry payments across WA — which companies pay providers there.
